Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

GangaGen Biotechnologies Private Limited, India (GBPL), is a biologics company specialized in discovering, designing and developing novel therapies for treating serious bacterial infections. GangaGen advanced it’s candidate compound into human clinical trials for the decolonization of Methicillin Resistant Staphylococcus aureus from human nares in 2015.GBPL is a wholly owned subsidiary of Bactoclear Holdings Pte. Ltd., a Sin...
GangaGen Biotechnologies Private Limited, India (GBPL), is a biologics company specialized in discovering, designing and developing novel therapies for treating serious bacterial infections. GangaGen advanced it’s candidate compound into human clinical trials for the decolonization of Methicillin Resistant Staphylococcus aureus from human nares in 2015.GBPL is a wholly owned subsidiary of Bactoclear Holdings Pte. Ltd., a Singapore company. The board of Bactoclear Holdings is made up of investors from different parts of the world, committed to make a difference in tackling antimicrobial resistance.

List your booth number for exhibitions, ask us

Contact Gangagen Biotechnologies and get a quotation

Gangagen Biotechnologies is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of P 128 bulk with DMF offered by Gangagen Biotechnologies